Kevin Tang’s Surge: Insider Buying Spree Signals Optimism for Boundless Bio’s Next Big Breakthrough
Inside Boundless Bio: Kevin Tang’s fresh 100k‑share buy signals optimism on ecDNA‑cancer therapy, partnership and leadership moves that could drive future upside.
3 minutes to read